Clinical Guidelines - Dual Diagnosis Guidelines

Service Planning Guidelines: Co-occurring Psychiatric and Substance Disorders
(Adobe Acrobat .PDF, 141K)

Ken Minkoff, MD, Private Practice, Harvard University
March, 2001


Motivational Enhancement for Dually Diagnosed Consumers (Adobe Acrobat .PDF, 89K)
Daniel D. Squires, M.S. and Theresa B. Moyers, Ph.D., University of New Mexico
October, 2001

Psychopharmacology Algorithm Project, Harvard Medical School (Adobe Acrobat .PDF, 9K)
David Osser, M.D.
BHRM Staff Note: The Psychopharmacology Algorithm Project includes a guideline for pharmacotherapy of anxiety
in patients with a history of chemical abuse or addiction.

Provision of Protective Payee Status (RP Guide) (Adobe Acrobat .PDF, 61K)
Dan Luchins, M.D. and David L. Roberts, M.A. and Patricia Hanrahan, Ph.D., University of Chicago
September, 2001

Treatment of PTSD and Substance Abuse (Adobe Acrobat, PDF, 95K)
Lisa M Najauits, Ph.D., McLean Hospital/Harvard Medical School
October, 2002

Comprehensive Continuous Integrated System of Care:  Psychopharmacology Practice Guidelines for Individuals with Co-occurring Psychiatric and Substance Abuse Disorders
(Adobe Acrobat .PDF, 153K)

Ken Minkoff, MD, Private Practice, Harvard University
January, 2005



Back to top


Center for Psychiatric Rehabilitation

Chestnut Health Systems logo
Copyright ©2001 Fayette Companies and Chestnut Health Systems